SGS Belgium

The research at SGS Belgium includes a strong focus on bacterial infections, virus diseases, and immune system diseases. Studies are looking at conditions such as chronic hepatitis B, chronic hepatitis D, influenza, respiratory syncytial virus infection, and human papilloma virus, with the goal of testing new vaccines and antiviral approaches, and improving protection against infection.

• Chronic hepatitis B and chronic hepatitis D infection
• Influenza and respiratory viral illness
• Vaccine development and immune response research

Much of this work is designed to evaluate safety, immune activity, and how well new preventive or treatment strategies perform in people.

This site is also active in respiratory tract diseases and related physiological processes, studying disorders such as asthma, chronic cough, non-cystic fibrosis bronchiectasis, pulmonary fibrosis, and asthma and COPD. The trials aim to assess new therapies and better understand symptom control, breathing outcomes, and treatment benefit.

• Asthma and asthma-COPD overlap
• Chronic cough and bronchiectasis
• Pulmonary fibrosis and other lung conditions

Several studies at SGS Belgium are focused on whether new respiratory medicines are safe, well tolerated, and effective in everyday clinical use.

Clinical research here covers nutritional and metabolic diseases, cardiovascular diseases, and digestive system diseases. Main areas include obesity, overweight, hypercholesterolaemia, atherosclerosis, non-alcoholic steatohepatitis, metabolic dysfunction-associated steatohepatitis, and liver cirrhosis. The purpose is to test new treatment options and better understand disease progression.

• Obesity and overweight
• Cholesterol and atherosclerosis
• Fatty liver disease and cirrhosis

These studies often explore whether investigational therapies can improve metabolic balance, liver health, and broader cardiometabolic outcomes.

The site conducts trials in nervous system diseases, immune system diseases, and congenital, hereditary, and neonatal diseases. Research includes Alzheimer’s disease, amyotrophic lateral sclerosis, multiple sclerosis, rheumatoid arthritis, atopic dermatitis, and Fragile X syndrome. The aim is to evaluate new therapies and improve understanding of difficult-to-treat conditions.

• Alzheimer’s disease and ALS
• Multiple sclerosis and inflammatory autoimmune disease
• Rare genetic and immune-mediated disorders

At SGS Belgium, this area of research is centered on safety, symptom improvement, and potential disease-modifying benefit.

Additional trials address female urogenital diseases and pregnancy complications as well as broader clinical questions in healthy volunteers. Examples include sleep disturbances associated with menopause and studies in healthy participants designed to understand how new medicines move through the body and how they are tolerated. The goal is to support better treatment decisions and early evaluation of promising therapies.

• Menopause-related sleep problems
• Healthy volunteer safety and tolerability studies
• Early assessment of new medicines and vaccines

This mix of research reflects the site’s broad clinical program, with work ranging from symptom-focused care to early testing of innovative treatments.